Angiocytotoxic Therapy in Human Non-Small Cell Lung Cancer Cell Lines: Advantage of Combined Effects of TNP-470 and SN-38

Authors

  • Hiroaki Satoh From the Department of Respiratory Medicine, Institute of Clinical Medicine (H. Satoh, H. Ishikawa, Y. T. Yamashita, M. Ohtsuka, S. Hasegawa), and the Department of Pathology, Institute of Basic Medical Sciences (M. Fujimoto, M. Fujiwara, T. Yazawa, H. Kamma), University of Tsukuba, Tsukuba-city, Japan
  • Hiroichi Ishikawa From the Department of Respiratory Medicine, Institute of Clinical Medicine (H. Satoh, H. Ishikawa, Y. T. Yamashita, M. Ohtsuka, S. Hasegawa), and the Department of Pathology, Institute of Basic Medical Sciences (M. Fujimoto, M. Fujiwara, T. Yazawa, H. Kamma), University of Tsukuba, Tsukuba-city, Japan
  • Mitsuo Fujimoto From the Department of Respiratory Medicine, Institute of Clinical Medicine (H. Satoh, H. Ishikawa, Y. T. Yamashita, M. Ohtsuka, S. Hasegawa), and the Department of Pathology, Institute of Basic Medical Sciences (M. Fujimoto, M. Fujiwara, T. Yazawa, H. Kamma), University of Tsukuba, Tsukuba-city, Japan
  • Masachika Fujiwara From the Department of Respiratory Medicine, Institute of Clinical Medicine (H. Satoh, H. Ishikawa, Y. T. Yamashita, M. Ohtsuka, S. Hasegawa), and the Department of Pathology, Institute of Basic Medical Sciences (M. Fujimoto, M. Fujiwara, T. Yazawa, H. Kamma), University of Tsukuba, Tsukuba-city, Japan
  • Yuko T. Yamashita From the Department of Respiratory Medicine, Institute of Clinical Medicine (H. Satoh, H. Ishikawa, Y. T. Yamashita, M. Ohtsuka, S. Hasegawa), and the Department of Pathology, Institute of Basic Medical Sciences (M. Fujimoto, M. Fujiwara, T. Yazawa, H. Kamma), University of Tsukuba, Tsukuba-city, Japan
  • Takuya Yazawa From the Department of Respiratory Medicine, Institute of Clinical Medicine (H. Satoh, H. Ishikawa, Y. T. Yamashita, M. Ohtsuka, S. Hasegawa), and the Department of Pathology, Institute of Basic Medical Sciences (M. Fujimoto, M. Fujiwara, T. Yazawa, H. Kamma), University of Tsukuba, Tsukuba-city, Japan
  • Morio Ohtsuka From the Department of Respiratory Medicine, Institute of Clinical Medicine (H. Satoh, H. Ishikawa, Y. T. Yamashita, M. Ohtsuka, S. Hasegawa), and the Department of Pathology, Institute of Basic Medical Sciences (M. Fujimoto, M. Fujiwara, T. Yazawa, H. Kamma), University of Tsukuba, Tsukuba-city, Japan
  • Shizuo Hasegawa From the Department of Respiratory Medicine, Institute of Clinical Medicine (H. Satoh, H. Ishikawa, Y. T. Yamashita, M. Ohtsuka, S. Hasegawa), and the Department of Pathology, Institute of Basic Medical Sciences (M. Fujimoto, M. Fujiwara, T. Yazawa, H. Kamma), University of Tsukuba, Tsukuba-city, Japan
  • Hiroshi Kamma From the Department of Respiratory Medicine, Institute of Clinical Medicine (H. Satoh, H. Ishikawa, Y. T. Yamashita, M. Ohtsuka, S. Hasegawa), and the Department of Pathology, Institute of Basic Medical Sciences (M. Fujimoto, M. Fujiwara, T. Yazawa, H. Kamma), University of Tsukuba, Tsukuba-city, Japan

DOI:

https://doi.org/10.1080/028418698423221

Abstract

No Abstract Available

Downloads

Download data is not yet available.

Downloads

Published

1998-01-01

How to Cite

Satoh, H. ., Ishikawa, H. ., Fujimoto, M. ., Fujiwara, M. ., Yamashita, Y. T. ., Yazawa, T. ., … Kamma, H. . (1998). Angiocytotoxic Therapy in Human Non-Small Cell Lung Cancer Cell Lines: Advantage of Combined Effects of TNP-470 and SN-38. Acta Oncologica, 37(1), 85–90. https://doi.org/10.1080/028418698423221

Issue

Vol. 37 No. 1 (1998): Acta Oncologica

Section

Articles